Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Howell

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|September 24, 2009
Survival prediction and gene identification with penalized global AUC maximizationZhenqiu Liu, Ronald B Gartenhaus, Xue-Wen Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2005
Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapyShengyuan Luo, William Cassidy, Lennox Jeffers, et al.
The AAPS Journal|May 29, 2012
Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infectionRunyan Jin, Michael J Fossler, John G McHutchison, et al.
The American Journal of Gastroenterology|October 24, 2012
Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1Runyan Jin, Ling Cai, Ming Tan, et al.
The Journal of Infectious Diseases|March 17, 2009
Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infectionJay H Hoofnagle, Abdus S Wahed, Robert S Brown, et al.
Medical Care|November 15, 2017
Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C PatientsViktor V Chirikov, Fadia T Shaya, Ebere Onukwugha, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2015
Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis CViktor V Chirikov, Fadia T Shaya, C Daniel Mullins, et al.
Gastroenterology|November 13, 2010
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis CHari S Conjeevaram, Abdus S Wahed, Nezam Afdhal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2004
Racial differences in liver inflammation and fibrosis related to chronic hepatitis CKester Crosse, Onuora G Umeadi, Frank A Anania, et al.
Clinical and Translational Science|September 3, 2011
IL28B genotype does not correlate with HIV control in African AmericansMohammad M Sajadi, Nahzinine Shakeri, Rohit Talwani, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|September 24, 2009
Survival prediction and gene identification with penalized global AUC maximizationZhenqiu Liu, Ronald B Gartenhaus, Xue-Wen Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2005
Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapyShengyuan Luo, William Cassidy, Lennox Jeffers, et al.
The AAPS Journal|May 29, 2012
Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infectionRunyan Jin, Michael J Fossler, John G McHutchison, et al.
The American Journal of Gastroenterology|October 24, 2012
Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1Runyan Jin, Ling Cai, Ming Tan, et al.
The Journal of Infectious Diseases|March 17, 2009
Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infectionJay H Hoofnagle, Abdus S Wahed, Robert S Brown, et al.
Medical Care|November 15, 2017
Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C PatientsViktor V Chirikov, Fadia T Shaya, Ebere Onukwugha, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2015
Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis CViktor V Chirikov, Fadia T Shaya, C Daniel Mullins, et al.
Gastroenterology|November 13, 2010
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis CHari S Conjeevaram, Abdus S Wahed, Nezam Afdhal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2004
Racial differences in liver inflammation and fibrosis related to chronic hepatitis CKester Crosse, Onuora G Umeadi, Frank A Anania, et al.
Clinical and Translational Science|September 3, 2011
IL28B genotype does not correlate with HIV control in African AmericansMohammad M Sajadi, Nahzinine Shakeri, Rohit Talwani, et al.
Pageof 5